On June 18th, BGI Genomics announced that due to the expiration of his term, Yin Ye, vice chairman of the board of directors of the company's third session, will no longer serve as vice chairman of the board of directors, non-independent director and member of the audit committee, but will continue to serve as director of some of the company's subsidiary holdings. As of the disclosure date of the announcement, Yin Ye directly holds 1.064 million shares of BGI Genomics.
尹烨不再担任华大基因副董事长
Yin Ye is no longer serving as the vice chairman of BGI Genomics.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.